NEXTSTELLIS® oral contraceptive has been nominated for the 2022 prix galien usa award for best pharmaceutical agent

/PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are pleased to announce NEXTSTELLIS®...

Related Keywords

Australia ,United States ,Salisbury ,Mashonaland East ,Zimbabwe ,France ,Adelaide ,South Australia ,Belgium ,Belgian ,Roland Mehl ,Mayne Pharma ,Prix Galien ,Mithra Pharmaceuticals ,Mayne Pharma Group Limited ,Women Health ,Galien Foundation ,Prix Galien United States Awards Committee ,Euronext Brussels ,Galien United States Award ,Best Pharmaceutical ,Prix Galien United States Awards Ceremony ,Best Pharmaceutical Agent ,Best Biotechnology Product ,Best Medical Technology ,Nobel Laureates ,Nobel Prize ,Mayne Pharma Group ,